title: Trial watch: an all-oral and interferon-free future for HCV therapy?
mesh_terms: D000284:Administration, Oral; D017326:Clinical Trials, Phase III as Topic / Q000639:trends*; D005544:Forecasting; D006526:Hepatitis C / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*; D012324:RNA-Dependent RNA Polymerase / Q000037:antagonists & inhibitors; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D017361:Viral Nonstructural Proteins; D007372:Interferons; D014542:Uridine Monophosphate; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase; D000069474:Sofosbuvir